FR2473886A1 - Perfectionnement aux procedes de concentration et de purification du facteur anti-hemophilique (facteur viii) et preparations de facteur viii concentre et purifie obtenues - Google Patents

Perfectionnement aux procedes de concentration et de purification du facteur anti-hemophilique (facteur viii) et preparations de facteur viii concentre et purifie obtenues Download PDF

Info

Publication number
FR2473886A1
FR2473886A1 FR8100741A FR8100741A FR2473886A1 FR 2473886 A1 FR2473886 A1 FR 2473886A1 FR 8100741 A FR8100741 A FR 8100741A FR 8100741 A FR8100741 A FR 8100741A FR 2473886 A1 FR2473886 A1 FR 2473886A1
Authority
FR
France
Prior art keywords
factor viii
cryoprecipitate
concentrate
improvement
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8100741A
Other languages
English (en)
French (fr)
Other versions
FR2473886B1 (en]
Inventor
Jean Francois Pla
Jacques Camille Liautaud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Merieux SA
Original Assignee
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Merieux SA filed Critical Institut Merieux SA
Publication of FR2473886A1 publication Critical patent/FR2473886A1/fr
Application granted granted Critical
Publication of FR2473886B1 publication Critical patent/FR2473886B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8100741A 1980-01-18 1981-01-16 Perfectionnement aux procedes de concentration et de purification du facteur anti-hemophilique (facteur viii) et preparations de facteur viii concentre et purifie obtenues Granted FR2473886A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/113,283 US4302445A (en) 1980-01-18 1980-01-18 Method for concentrating and purifying antihemophilic factor or factor VIII

Publications (2)

Publication Number Publication Date
FR2473886A1 true FR2473886A1 (fr) 1981-07-24
FR2473886B1 FR2473886B1 (en]) 1984-03-09

Family

ID=22348567

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8100741A Granted FR2473886A1 (fr) 1980-01-18 1981-01-16 Perfectionnement aux procedes de concentration et de purification du facteur anti-hemophilique (facteur viii) et preparations de facteur viii concentre et purifie obtenues

Country Status (3)

Country Link
US (1) US4302445A (en])
DE (1) DE3101001A1 (en])
FR (1) FR2473886A1 (en])

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0076870A1 (en) * 1981-10-12 1983-04-20 Armour Pharmaceutical Company Process for the preparation of highly purified antihemophilic factor

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
EP0126789B1 (en) * 1983-05-27 1989-01-25 Miles Inc. Antihemophilic factor concentrate and process for its preparation
US5149787A (en) * 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US4710381A (en) * 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US5043428A (en) * 1984-08-31 1991-08-27 Behringwerke Aktiengesellschaft Pasteurized, isoagglutinin-free factor VIII preparation and a process for its production
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
JPH0719215B2 (ja) * 1989-06-01 1995-03-06 三菱電機株式会社 マイクロプロセッサ

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2267113A1 (en]) * 1974-04-12 1975-11-07 Squibb & Sons Inc
FR2293943A1 (fr) * 1974-12-14 1976-07-09 Biotest Serum Institut Gmbh Procede pour la preparation simultanee a partir d'un produit de depart, d'un concentre de globuline a, d'un complexe de prothrombine et d'une solution de proteines du serum therapeutiquement utilisables
LU75741A1 (en]) * 1976-09-07 1977-04-28
DE2636757A1 (de) * 1976-08-14 1978-02-16 Recherches Hematologiques Verfahren zum aufkonzentrieren und reinigen des antihaemophiliefaktors
FR2363577A1 (fr) * 1976-09-03 1978-03-31 Recherches Hematologiques Procede simplifie pour preparer avec un rendement eleve du concentre de facteur antihemophilique pur
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production
US4188318A (en) * 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104266A (en) * 1977-04-14 1978-08-01 American National Red Cross Method for preparation of antihemophilic factor

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2267113A1 (en]) * 1974-04-12 1975-11-07 Squibb & Sons Inc
FR2293943A1 (fr) * 1974-12-14 1976-07-09 Biotest Serum Institut Gmbh Procede pour la preparation simultanee a partir d'un produit de depart, d'un concentre de globuline a, d'un complexe de prothrombine et d'une solution de proteines du serum therapeutiquement utilisables
US4188318A (en) * 1975-06-16 1980-02-12 Edward Shanbrom Simplified method for preparation of high yield, high purity Factor VIII concentrate
DE2636757A1 (de) * 1976-08-14 1978-02-16 Recherches Hematologiques Verfahren zum aufkonzentrieren und reinigen des antihaemophiliefaktors
NL7609349A (nl) * 1976-08-14 1978-02-27 Recherches Hematologiques Werkwijze voor het bereiden van een concen- traat van een zeer zuivere faktor viii.
AT349639B (de) * 1976-08-14 1979-04-10 Recherches Hematologiques Verfahren zum aufkonzentrieren und reinigen des antihaemophiliefaktors
GB1551928A (en) * 1976-08-14 1979-09-05 Recherches Hematologiques Method for preparation of factor viii concentrate
FR2363577A1 (fr) * 1976-09-03 1978-03-31 Recherches Hematologiques Procede simplifie pour preparer avec un rendement eleve du concentre de facteur antihemophilique pur
LU75741A1 (en]) * 1976-09-07 1977-04-28
US4170639A (en) * 1978-07-10 1979-10-09 Warner-Lambert Company Antihemophilic factor concentrate and its production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1967 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0076870A1 (en) * 1981-10-12 1983-04-20 Armour Pharmaceutical Company Process for the preparation of highly purified antihemophilic factor

Also Published As

Publication number Publication date
DE3101001A1 (de) 1981-12-03
US4302445A (en) 1981-11-24
FR2473886B1 (en]) 1984-03-09

Similar Documents

Publication Publication Date Title
JP3094167B2 (ja) 免疫血清グロブリンの精製方法
EP0359593B2 (fr) Séparation chromatographique des protéines du plasma, notamment du facteur VIII, du facteur von Willebrand, de la fibronectine et du fibrinogène
US4069216A (en) Simplified methods for preparation of very high purity Factor VIII concentrate
BE1004178A3 (fr) Procede de preparation a l'echelle industrielle d'un concentre de facteur von willebrand humain standardise, de tres haute purete, approprie a un usage therapeutique.
US4156681A (en) Process for isolating albumin from blood
EP0416983B1 (fr) Procédé de préparation de concentré du complexe Facteur VIII-facteur von Willebrand de la coagulation sanguine à partir de plasma total
HU182554B (en) Process for producing preparation of serum protein for intravenous application
US5250662A (en) Albumin purification
AU2004200745B8 (en) Process for Removing Viruses in Fibrinogen Solutions and Fibrinogen Obtained by Said Process
US4404131A (en) Method of producing a factor-VIII(AHF)-high-concentrate
CA1323139C (en) Method of producing substantially pure albumin
FR2473886A1 (fr) Perfectionnement aux procedes de concentration et de purification du facteur anti-hemophilique (facteur viii) et preparations de facteur viii concentre et purifie obtenues
FR2548670A1 (fr) Procede de preparation des principales proteines du sang hemolyse sous forme non denaturee
EP0402205A1 (fr) Procédé de préparation de solutions d'albumine purifiée
WO1999031138A1 (fr) Procede de preparation par filtration d'une solution de facteur viii securisee viralement
EP0555135B1 (fr) Procédé de fabrication de fibrinogène de très haute pureté
FR2488510A1 (fr) Procede de separation de l'antigene de surface de l'hepatite b
CA1101332A (fr) Procedes simplifies pour la preparation de concentres de facteur viii de tres grande purete
EP0383645B1 (fr) Procédé de fabrication du facteur antihémophilique (FVIIIc) ayant une très haute pureté.
EP0422769A1 (en) Albumin purification
EP1632501A1 (fr) Procédé de préparation d'un concentré de facteur von Willebrand (FvW) par voie chromatographique et concentré de FvW susceptible d'être ainsi obtenu
FR2635114A1 (fr) Procede de traitement de solutions proteiques contenant des pigments tels que groupements heminiques ou chlorophylles en vue de leur decoloration et produits obtenus
IE45013B1 (en) Improvements in or relating to the preparation of insulin
JP2524538B2 (ja) ヘム鉄複合物の製造方法
KR830002718B1 (ko) 혈장으로부터 알부민을 분리 제조하는 방법

Legal Events

Date Code Title Description
ST Notification of lapse